Response to Marcus et al. Letter

Abstract

Back to table of contents Previous article Next article Communications and UpdatesFull AccessResponse to Marcus et al. LetterJoel Yager, M.D., Alan J. Gelenberg, M.D., and Laura J. Fochtmann, M.D.Joel YagerChair, APA Steering Committee on Practice Guidelines Denver, Colo.Search for more papers by this author, M.D., Alan J. GelenbergChair, APA Work Group on Major Depressive Disorder Hershey, Pa.Search for more papers by this author, M.D., and Laura J. FochtmannMedical Editor, APA Practice Guidelines Stony Brook, N.Y.Search for more papers by this author, M.D.Published Online:1 Feb 2011https://doi.org/10.1176/appi.ajp.2010.10101515rAboutSectionsPDF/EPUB ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinked InEmail To the Editor: We thank Dr. Marcus et al. for bringing this error to our attention. The upper dose of aripiprazole studied for adjunctive treatment of major depressive disorder is 20 mg/day, and the upper recommended dose is 15 mg/day. A correction will be made in the guideline text published on PsychiatryOnline.com.Chair, APA Steering Committee on Practice Guidelines Denver, Colo.Chair, APA Work Group on Major Depressive Disorder Hershey, Pa.Medical Editor, APA Practice Guidelines Stony Brook, N.Y.The authors' disclosures accompany the APA Practice Guideline.accepted for publication in December 2010. FiguresReferencesCited byDetailsCited ByNone Volume 168Issue 2 February 2011Pages 211-211 Metrics PDF download History Accepted 1 December 2010 Published online 1 February 2011 Published in print 1 February 2011